ARDX
Ardelyx, Inc. Healthcare - Biotechnology Investor Relations →
Ardelyx, Inc. (ARDX) closed at $5.31 as of 2026-03-20, trading 12.6% above its 200-week moving average of $4.71. The stock is currently moving closer to the line, down from 23.2% last week. The 14-week RSI sits at 45, indicating neutral momentum.
Trading volume is running at 1.2x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.49 ratio) is neutral — neither side is clearly dominating.
Over the past 565 weeks of data, ARDX has crossed below its 200-week moving average 14 times. On average, these episodes lasted 25 weeks. The average one-year return after crossing below was -4.1%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $1302 million, ARDX is a small-cap stock. The company generates a free cash flow yield of 0.5%. Return on equity stands at -36.2%. The stock trades at 7.8x book value.
Share count has increased 23.1% over three years, indicating dilution.
Over the past 10.9 years, a hypothetical investment of $100 in ARDX would have grown to $48, compared to $369 for the S&P 500. ARDX has returned -6.4% annualized vs 12.7% for the index, underperforming the broader market over this period.
In the past 12 months, corporate insiders have made 5 open-market purchases totaling $5,349,527.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: ARDX vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After ARDX Crosses Below the Line?
Across 14 historical episodes, buying ARDX when it crossed below its 200-week moving average produced an average return of -7.6% after 12 months (median -18.0%), compared to +22.2% for the S&P 500 over the same periods. 42% of those episodes were profitable after one year. After 24 months, the average return was -40.1% vs +38.6% for the index.
Each line shows $100 invested at the moment ARDX crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
ARDX has crossed below its 200-week MA 14 times with an average 1-year return of +-4.1% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| May 2015 | Jul 2015 | 8 | 37.6% | -19.2% | -51.5% |
| Aug 2015 | Aug 2015 | 1 | 0.3% | -43.1% | -69.5% |
| Oct 2015 | Nov 2015 | 2 | 10.5% | -16.7% | -66.5% |
| Nov 2015 | Nov 2015 | 1 | 2.6% | -11.0% | -69.2% |
| Jan 2016 | Nov 2016 | 44 | 57.9% | +29.2% | -50.5% |
| Nov 2016 | Dec 2019 | 158 | 82.8% | -55.7% | -64.1% |
| Mar 2020 | Apr 2020 | 6 | 19.3% | +6.5% | -15.2% |
| Apr 2020 | May 2020 | 1 | 0.6% | +13.5% | -17.5% |
| Jul 2020 | Nov 2020 | 15 | 10.2% | -69.2% | -6.0% |
| Jul 2021 | Mar 2023 | 88 | 86.6% | -58.6% | +216.1% |
| May 2023 | Aug 2023 | 15 | 20.3% | +120.0% | +49.6% |
| Sep 2023 | Nov 2023 | 8 | 16.7% | +55.2% | +34.4% |
| May 2025 | May 2025 | 1 | 3.5% | N/A | +46.7% |
| May 2025 | Jun 2025 | 5 | 6.0% | N/A | +44.7% |
| Average | 25 | — | +-4.1% | — |
Frequently Asked Questions
Is ARDX below its 200-week moving average?
No. Ardelyx, Inc. (ARDX) is currently 12.6% above its 200-week moving average of $4.71. It would need to fall to $4.71 to cross below the line.
What is ARDX's 200-week moving average price?
Ardelyx, Inc.'s 200-week moving average is $4.71 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when ARDX drops below its 200-week moving average?
ARDX has crossed below its 200-week moving average 14 times in our data. The average one-year return after these crossings was -4.1%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 25 weeks on average.
Is ARDX a good value right now?
Here's what our data says about ARDX as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 45. Free cash flow yield is 0.5%. Return on equity is -36.2%. Price-to-book is 7.8x. This is not a buy or sell recommendation — always do your own research.
How does ARDX compare to the S&P 500?
Over the past 10.9 years, $100 invested in ARDX would have grown to $48, compared to $369 for the S&P 500. That's -6.4% annualized vs 12.7% for the index. ARDX has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20